APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pain Reliever

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pain Reliever Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchPain Reliever Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pain Reliever Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pain Reliever Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pain Reliever Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pain Reliever Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pain Reliever market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pain Reliever is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pain Reliever include Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pain Reliever market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain Reliever and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain Reliever sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain Reliever market size, projected growth trends, production technologies, key applications, and end-use industries.

Pain Reliever Segment by Company

Teva

Sanofi

J&J

Merck

Eli Lilly

Pfizer

GSK

Bayer

AstraZeneca

Yunnan Baiyao

Purdue

Grunenthal

Endo

Depomed

Allergan

Pain Reliever Segment by Type

Branded Opioids

NSAIDs

Generic Opioids

Others

Pain Reliever Segment by Application

Hospitals

Clinics

Drugstores

Pain Reliever Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Reliever market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Reliever and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Reliever.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pain Reliever market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pain Reliever manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pain Reliever in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pain Reliever in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pain Reliever Industry Trends Table 2. Pain Reliever Industry Drivers Table 3. Pain Reliever Industry Opportunities and Challenges Table 4. Pain Reliever Industry Restraints Table 5. Global Pain Reliever Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pain Reliever Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pain Reliever Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pain Reliever Sales Market Share by Manufacturers Table 9. Global Pain Reliever Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pain Reliever Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pain Reliever Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pain Reliever Manufacturers, Product Type & Application Table 13. Global Pain Reliever Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pain Reliever by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Branded Opioids Table 17. Major Manufacturers of NSAIDs Table 18. Major Manufacturers of Generic Opioids Table 19. Major Manufacturers of Others Table 20. Global Pain Reliever Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pain Reliever Sales by Type (2021-2026) & (K Units) Table 22. Global Pain Reliever Sales by Type (2027-2032) & (K Units) Table 23. Global Pain Reliever Sales Market Share by Type (2021-2026) Table 24. Global Pain Reliever Sales Market Share by Type (2027-2032) Table 25. Global Pain Reliever Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Pain Reliever Revenue by Type (2021-2026) & (K Units) Table 27. Global Pain Reliever Revenue by Type (2027-2032) & (K Units) Table 28. Global Pain Reliever Revenue Market Share by Type (2021-2026) Table 29. Global Pain Reliever Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinics Table 32. Major Manufacturers of Drugstores Table 33. Global Pain Reliever Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pain Reliever Sales by Application (2021-2026) & (K Units) Table 35. Global Pain Reliever Sales by Application (2027-2032) & (K Units) Table 36. Global Pain Reliever Sales Market Share by Application (2021-2026) Table 37. Global Pain Reliever Sales Market Share by Application (2027-2032) Table 38. Global Pain Reliever Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pain Reliever Revenue by Application (2021-2026) & (K Units) Table 40. Global Pain Reliever Revenue by Application (2027-2032) & (K Units) Table 41. Global Pain Reliever Revenue Market Share by Application (2021-2026) Table 42. Global Pain Reliever Revenue Market Share by Application (2027-2032) Table 43. Global Pain Reliever Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pain Reliever Sales by Region (2021-2026) & (K Units) Table 45. Global Pain Reliever Sales Market Share by Region (2021-2026) Table 46. Global Pain Reliever Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Pain Reliever Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Pain Reliever Sales by Country (2021-2026) & (K Units) Table 50. North America Pain Reliever Sales by Country (2027-2032) & (K Units) Table 51. Europe Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Pain Reliever Sales by Country (2021-2026) & (K Units) Table 53. Europe Pain Reliever Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Pain Reliever Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Pain Reliever Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Pain Reliever Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Pain Reliever Sales by Country (2027-2032) & (K Units) Table 60. Global Pain Reliever Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pain Reliever Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pain Reliever Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pain Reliever Revenue Market Share by Region (2021-2026) Table 64. Global Pain Reliever Revenue Market Share by Region (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pain Reliever Product Portfolio Table 69. Teva Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sanofi Pain Reliever Product Portfolio Table 74. Sanofi Recent Development Table 75. J&J Company Information Table 76. J&J Business Overview Table 77. J&J Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. J&J Pain Reliever Product Portfolio Table 79. J&J Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merck Pain Reliever Product Portfolio Table 84. Merck Recent Development Table 85. Eli Lilly Company Information Table 86. Eli Lilly Business Overview Table 87. Eli Lilly Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Eli Lilly Pain Reliever Product Portfolio Table 89. Eli Lilly Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Pain Reliever Product Portfolio Table 94. Pfizer Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. GSK Pain Reliever Product Portfolio Table 99. GSK Recent Development Table 100. Bayer Company Information Table 101. Bayer Business Overview Table 102. Bayer Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Bayer Pain Reliever Product Portfolio Table 104. Bayer Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. AstraZeneca Pain Reliever Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Yunnan Baiyao Company Information Table 111. Yunnan Baiyao Business Overview Table 112. Yunnan Baiyao Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Yunnan Baiyao Pain Reliever Product Portfolio Table 114. Yunnan Baiyao Recent Development Table 115. Purdue Company Information Table 116. Purdue Business Overview Table 117. Purdue Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Purdue Pain Reliever Product Portfolio Table 119. Purdue Recent Development Table 120. Grunenthal Company Information Table 121. Grunenthal Business Overview Table 122. Grunenthal Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Grunenthal Pain Reliever Product Portfolio Table 124. Grunenthal Recent Development Table 125. Endo Company Information Table 126. Endo Business Overview Table 127. Endo Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Endo Pain Reliever Product Portfolio Table 129. Endo Recent Development Table 130. Depomed Company Information Table 131. Depomed Business Overview Table 132. Depomed Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Depomed Pain Reliever Product Portfolio Table 134. Depomed Recent Development Table 135. Allergan Company Information Table 136. Allergan Business Overview Table 137. Allergan Pain Reliever Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Allergan Pain Reliever Product Portfolio Table 139. Allergan Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Pain Reliever Distributors List Table 143. Pain Reliever Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Pain Reliever Product Image Figure 2. Global Pain Reliever Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Reliever Market Size (2021-2032) & (US$ Million) Figure 4. Global Pain Reliever Sales (2021-2032) & (K Units) Figure 5. Global Pain Reliever Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pain Reliever Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Branded Opioids Image Figure 9. NSAIDs Image Figure 10. Generic Opioids Image Figure 11. Others Image Figure 12. Global Pain Reliever Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pain Reliever Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pain Reliever Sales Market Share by Type (2021-2032) Figure 15. Global Pain Reliever Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Pain Reliever Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pain Reliever Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Drugstores Image Figure 21. Global Pain Reliever Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pain Reliever Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pain Reliever Sales Market Share by Application (2021-2032) Figure 24. Global Pain Reliever Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Pain Reliever Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pain Reliever Revenue Market Share by Application (2021-2032) Figure 27. North America Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Pain Reliever Sales Market Share by Country (2021-2032) Figure 29. U.S. Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Pain Reliever Sales Market Share by Country (2021-2032) Figure 34. Germany Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Pain Reliever Sales Market Share by Country (2021-2032) Figure 41. China Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Pain Reliever Sales Market Share by Country (2021-2032) Figure 49. Brazil Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Pain Reliever Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Pain Reliever Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pain Reliever Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pain Reliever Revenue (2021-2032) & (US$ Million) Figure 60. North America Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pain Reliever Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pain Reliever Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pain Reliever Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pain Reliever Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pain Reliever Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Branded Opioids
  • NSAIDs
  • Generic Opioids
  • Others
Applications
  • Hospitals
  • Clinics
  • Drugstores
Companies covered
  • Teva
  • Sanofi
  • J&J
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Yunnan Baiyao
  • Purdue
  • Grunenthal
  • Endo
  • Depomed
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pain Reliever Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pain Reliever Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pain Reliever Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pain Reliever Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pain Reliever Market Dynamics
  1. 2.1 Pain Reliever Industry Trends
  2. 2.2 Pain Reliever Industry Drivers
  3. 2.3 Pain Reliever Industry Opportunities and Challenges
  4. 2.4 Pain Reliever Industry Restraints
3 Pain Reliever Market by Manufacturers
  1. 3.1 Global Pain Reliever Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pain Reliever Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pain Reliever Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pain Reliever Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pain Reliever Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pain Reliever Manufacturers, Product Type & Application
  7. 3.7 Global Pain Reliever Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pain Reliever Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pain Reliever Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pain Reliever Tier 1, Tier 2, and Tier 3
4 Pain Reliever Market by Type
  1. 4.1 Pain Reliever Type Introduction
  2. 4.1.1 Branded Opioids
  3. 4.1.2 NSAIDs
  4. 4.1.3 Generic Opioids
  5. 4.1.4 Others
  6. 4.2 Global Pain Reliever Sales by Type
  7. 4.2.1 Global Pain Reliever Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pain Reliever Sales by Type (2021-2032)
  9. 4.2.3 Global Pain Reliever Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pain Reliever Revenue by Type
  11. 4.3.1 Global Pain Reliever Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pain Reliever Revenue by Type (2021-2032)
  13. 4.3.3 Global Pain Reliever Revenue Market Share by Type (2021-2032)
5 Pain Reliever Market by Application
  1. 5.1 Pain Reliever Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstores
  5. 5.2 Global Pain Reliever Sales by Application
  6. 5.2.1 Global Pain Reliever Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain Reliever Sales by Application (2021-2032)
  8. 5.2.3 Global Pain Reliever Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pain Reliever Revenue by Application
  10. 5.3.1 Global Pain Reliever Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pain Reliever Revenue by Application (2021-2032)
  12. 5.3.3 Global Pain Reliever Revenue Market Share by Application (2021-2032)
6 Global Pain Reliever Sales by Region
  1. 6.1 Global Pain Reliever Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain Reliever Sales by Region (2021-2032)
  3. 6.2.1 Global Pain Reliever Sales by Region (2021-2026)
  4. 6.2.2 Global Pain Reliever Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pain Reliever Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pain Reliever Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pain Reliever Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pain Reliever Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pain Reliever Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pain Reliever Revenue by Region
  1. 7.1 Global Pain Reliever Revenue by Region
  2. 7.1.1 Global Pain Reliever Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pain Reliever Revenue by Region (2021-2026)
  4. 7.1.3 Global Pain Reliever Revenue by Region (2027-2032)
  5. 7.1.4 Global Pain Reliever Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pain Reliever Revenue (2021-2032)
  8. 7.2.2 North America Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pain Reliever Revenue (2021-2032)
  11. 7.3.2 Europe Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pain Reliever Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pain Reliever Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pain Reliever Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pain Reliever Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pain Reliever Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 J&J
  14. 8.3.1 J&J Company Information
  15. 8.3.2 J&J Business Overview
  16. 8.3.3 J&J Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 J&J Pain Reliever Product Portfolio
  18. 8.3.5 J&J Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Pain Reliever Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Eli Lilly
  26. 8.5.1 Eli Lilly Company Information
  27. 8.5.2 Eli Lilly Business Overview
  28. 8.5.3 Eli Lilly Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly Pain Reliever Product Portfolio
  30. 8.5.5 Eli Lilly Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Pain Reliever Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Pain Reliever Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Pain Reliever Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Pain Reliever Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Yunnan Baiyao
  56. 8.10.1 Yunnan Baiyao Company Information
  57. 8.10.2 Yunnan Baiyao Business Overview
  58. 8.10.3 Yunnan Baiyao Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yunnan Baiyao Pain Reliever Product Portfolio
  60. 8.10.5 Yunnan Baiyao Recent Developments
  61. 8.11 Purdue
  62. 8.11.1 Purdue Company Information
  63. 8.11.2 Purdue Business Overview
  64. 8.11.3 Purdue Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Purdue Pain Reliever Product Portfolio
  66. 8.11.5 Purdue Recent Developments
  67. 8.12 Grunenthal
  68. 8.12.1 Grunenthal Company Information
  69. 8.12.2 Grunenthal Business Overview
  70. 8.12.3 Grunenthal Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Grunenthal Pain Reliever Product Portfolio
  72. 8.12.5 Grunenthal Recent Developments
  73. 8.13 Endo
  74. 8.13.1 Endo Company Information
  75. 8.13.2 Endo Business Overview
  76. 8.13.3 Endo Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Endo Pain Reliever Product Portfolio
  78. 8.13.5 Endo Recent Developments
  79. 8.14 Depomed
  80. 8.14.1 Depomed Company Information
  81. 8.14.2 Depomed Business Overview
  82. 8.14.3 Depomed Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Depomed Pain Reliever Product Portfolio
  84. 8.14.5 Depomed Recent Developments
  85. 8.15 Allergan
  86. 8.15.1 Allergan Company Information
  87. 8.15.2 Allergan Business Overview
  88. 8.15.3 Allergan Pain Reliever Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Allergan Pain Reliever Product Portfolio
  90. 8.15.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pain Reliever Value Chain Analysis
  2. 9.1.1 Pain Reliever Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pain Reliever Production Mode & Process
  6. 9.2 Pain Reliever Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pain Reliever Distributors
  9. 9.2.3 Pain Reliever Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst